Your browser doesn't support javascript.
loading
Growth in ataxia telangiectasia.
Natale, Valerie A I; Cole, Tim J; Rothblum-Oviatt, Cynthia; Wright, Jennifer; Crawford, Thomas O; Lefton-Greif, Maureen A; McGrath-Morrow, Sharon A; Schlechter, Haley; Lederman, Howard M.
Afiliación
  • Natale VAI; Forgotten Diseases Research Foundation, Santa Clara, CA, USA. vnatale@forgottendiseases.org.
  • Cole TJ; UCL Great Ormond Street Institute of Child Health, London, UK.
  • Rothblum-Oviatt C; A-T Children's Project, Coconut Creek, FL, USA.
  • Wright J; Division of Pediatric Allergy and Immunology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Crawford TO; Departments of Pediatrics and Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Lefton-Greif MA; Departments of Pediatrics, Otolaryngology-Head and Neck Surgery, and Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • McGrath-Morrow SA; Children's Hospital of Philadelphia Division of Pulmonary Medicine and Sleep, Philadelphia, PA, USA.
  • Schlechter H; Institute for Clinical and Translational Research, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Lederman HM; Institute for Clinical and Translational Research, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Orphanet J Rare Dis ; 16(1): 123, 2021 03 10.
Article en En | MEDLINE | ID: mdl-33691726
ABSTRACT

BACKGROUND:

Ataxia telangiectasia (A-T) is a DNA repair disorder that affects multiple body systems. Neurological problems and immunodeficiency are two important features of this disease. At this time, two main severity groups are defined in A-T classic (the more severe form) and mild. Poor growth is a common problem in classic A-T. An objective of this study was to develop growth references for classic A-T. Another objective was to compare growth patterns in classic A-T and mild A-T with each other and with the general population, using the CDC growth references. A final objective was to examine the effects of chronic infection on height.

RESULTS:

We found that classic A-T patients were smaller overall, and suffered from height and weight faltering that continued throughout childhood and adolescence. When compared to the CDC growth references, the median heights and weights for both male and female patients eventually fell to or below the 3rd centile on the CDC charts. Height faltering was more pronounced in females. Birthweight was lower in the classic A-T group compared to mild A-T and the general population, whereas birth length was not. Finally, we investigated height and BMI faltering in relation to number of infections and found no association.

CONCLUSIONS:

Classic A-T appears to affect growth in utero. Although children appear to grow well in very early life, faltering begins early, and is unrelenting.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ataxia Telangiectasia Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: Orphanet J Rare Dis Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ataxia Telangiectasia Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: Orphanet J Rare Dis Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos